Stay updated on Relatlimab Safety in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Safety in B-Cell Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was applied, replacing the previous v3.3.3; this is a minor header-level update with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T05:40:14.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Locations section added with site listings and page revision updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-17T18:43:32.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed auto-generated text and revision note of v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-26T08:31:33.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The generic funding-status notice on the page was removed; the core study details (title, conditions, locations, eligibility) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:00:09.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic UI/layout adjustments that do not modify the study details, inclusion/exclusion criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T02:41:36.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    - Added a government funding and operating-status notice (impactful; affects reliability and user expectations). - Updated software version to v3.2.0 (administrative change). - Removed the specific term 'B-cell chronic lymphocytic leukemia' (removal of a medical term; less impactful unless the page was about diseases).
    Difference
    3%
    Check dated 2025-10-06T15:58:43.000Z thumbnail image

Stay in the know with updates to Relatlimab Safety in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.